103 related articles for article (PubMed ID: 9395092)
21. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
[TBL] [Abstract][Full Text] [Related]
22. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
23. Opioid diketopiperazines: synthesis and activity of a prototypic class of opioid antagonists.
Balboni G; Guerrini R; Salvadori S; Tomatis R; Bryant SD; Bianchi C; Attila M; Lazarus LH
Biol Chem; 1997 Jan; 378(1):19-29. PubMed ID: 9049061
[TBL] [Abstract][Full Text] [Related]
24. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
Tancredi T; Salvadori S; Amodeo P; Picone D; Lazarus LH; Bryant SD; Guerrini R; Marzola G; Temussi PA
Eur J Biochem; 1994 Aug; 224(1):241-7. PubMed ID: 8076645
[TBL] [Abstract][Full Text] [Related]
25. A novel cyclic enkephalin analogue with potent opioid antagonist activity.
Weltrowska G; Lu Y; Lemieux C; Chung NN; Schiller PW
Bioorg Med Chem Lett; 2004 Sep; 14(18):4731-3. PubMed ID: 15324897
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
27. Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold.
Adamska-Bartłomiejczyk A; De Marco R; Gentilucci L; Kluczyk A; Janecka A
Bioorg Med Chem; 2017 Apr; 25(8):2399-2405. PubMed ID: 28318893
[TBL] [Abstract][Full Text] [Related]
28. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
29. Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models.
Wang C; McFadyen IJ; Traynor JR; Mosberg HI
Bioorg Med Chem Lett; 1998 Oct; 8(19):2685-8. PubMed ID: 9873603
[TBL] [Abstract][Full Text] [Related]
30. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
[TBL] [Abstract][Full Text] [Related]
31. Potent opioid peptide agonists containing 4'-[N-((4'-phenyl)-phenethyl)carboxamido]phenylalanine (Bcp) in place of Tyr.
Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Schiller PW
Chem Biol Drug Des; 2008 Nov; 72(5):337-40. PubMed ID: 19012569
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
33. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
[TBL] [Abstract][Full Text] [Related]
34. Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore.
Balboni G; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
J Med Chem; 2009 Sep; 52(17):5556-9. PubMed ID: 19642675
[TBL] [Abstract][Full Text] [Related]
35. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
36. [Identification of a functionally important dipeptide in sequences of atypical opioid peptides].
Guzevatykh LS
Bioorg Khim; 2008; 34(5):591-609. PubMed ID: 19060934
[TBL] [Abstract][Full Text] [Related]
37. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
Hruby VJ; Agnes RS
Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
[TBL] [Abstract][Full Text] [Related]
38. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
39. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
40. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures.
Flippen-Anderson JL; Deschamps JR; George C; Reddy PA; Lewin AH; Brine GA; Sheldrick G; Nikiforovich G
J Pept Res; 1997 May; 49(5):384-93. PubMed ID: 9211219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
